Simplex Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,076
| Closed | -$1.79M | – | 8929 |
|
|
2025
Q4 | $1.85M | Sell |
8,076
-98,008
| -92% | -$22.3M | ﹤0.01% | 2045 |
|
|
2025
Q3 | $24.6M | Buy |
+106,084
| New | +$21.6M | 0.01% | 559 |
|
|
2024
Q1 | – | Sell |
-16,776
| Closed | -$2.89M | – | 8705 |
|
|
2023
Q4 | $2.6M | Sell |
16,776
-107,476
| -86% | -$15.7M | ﹤0.01% | 2149 |
|
|
2023
Q3 | $18.5M | Buy |
124,252
+69,611
| +127% | +$10.2M | 0.01% | 626 |
|
|
2023
Q2 | $7.36M | Sell |
54,641
-12,885
| -19% | -$1.89M | 0.01% | 1073 |
|
|
2023
Q1 | $10.8M | Buy |
67,526
+52,483
| +349% | +$8.02M | 0.01% | 856 |
|
|
2022
Q4 | $2.43M | Sell |
15,043
-25,915
| -63% | -$3.97M | ﹤0.01% | 1717 |
|
|
2022
Q3 | $5.5M | Buy |
+40,958
| New | +$5.88M | 0.01% | 1135 |
|
|
2022
Q2 | – | Sell |
-41,399
| Closed | -$6.33M | – | 9804 |
|
|
2022
Q1 | $6.71M | Buy |
+41,399
| New | +$6.01M | 0.01% | 1053 |
|
|
2021
Q4 | – | Sell |
-593
| Closed | -$70K | – | 10347 |
|
|
2021
Q3 | $67K | Buy |
+593
| New | +$67.8K | ﹤0.01% | 7137 |
|
|
2021
Q1 | – | Sell |
-104,098
| Closed | -$11.1M | – | 8626 |
|
|
2020
Q4 | $11.2M | Buy |
104,098
+103,998
| +103,998% | +$9.99M | 0.01% | 537 |
|
|
2020
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 6875 |
|
|
2020
Q2 | $9K | Buy |
+100
| New | +$8.8K | ﹤0.01% | 6691 |
|
|
2020
Q1 | – | Sell |
-259,224
| Closed | -$22.1M | – | 7493 |
|
|
2019
Q4 | $23M | Buy |
+259,224
| New | +$21.5M | 0.05% | 248 |
|
|
2019
Q3 | – | Sell |
-64,174
| Closed | -$4.4M | – | 7149 |
|
|
2019
Q2 | $4.67M | Buy |
+64,174
| New | +$5.04M | 0.01% | 714 |
|
|
2019
Q1 | – | Sell |
-27,149
| Closed | -$2.22M | – | 7031 |
|
|
2018
Q4 | $2.5M | Buy |
+27,149
| New | +$2.39M | 0.01% | 950 |
|
|
2018
Q2 | – | Sell |
-41,700
| Closed | -$4.07M | – | 7283 |
|
|
2018
Q1 | $3.95M | Sell |
41,700
-200
| -0.5% | -$22K | 0.17% | 103 |
|
|
2017
Q4 | $4.05M | Buy |
41,900
+19,104
| +84% | +$1.8M | 0.17% | 102 |
|
|
2017
Q3 | $2.02M | Sell |
22,796
-76,830
| -77% | -$5.85M | 0.08% | 186 |
|
|
2017
Q2 | $7.22M | Sell |
99,626
-150,208
| -60% | -$10.1M | 0.31% | 52 |
|
|
2017
Q1 | $16.3M | Buy |
+249,834
| New | +$15.7M | 0.7% | 24 |
|
|
2016
Q2 | – | Sell |
-9,340
| Closed | -$569K | – | 5712 |
|
|
2016
Q1 | $533K | Buy |
+9,340
| New | +$521K | 0.04% | 414 |
|
|
2015
Q4 | – | Sell |
-54,799
| Closed | -$3.16M | – | 5277 |
|
|
2015
Q3 | $2.98M | Buy |
54,799
+27,448
| +100% | +$1.79M | 0.22% | 82 |
|
|
2015
Q2 | $1.84M | Sell |
27,351
-35,660
| -57% | -$2.33M | 0.15% | 107 |
|
|
2015
Q1 | $3.69M | Buy |
+63,011
| New | +$3.81M | 0.43% | 35 |
|
Other funds holding ABBV
VCM
VPM
Simplex Trading's ABBV Position: Q1 2026 in Review
Simplex Trading sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 8,076 shares — an estimated $1.79M sold.
Simplex Trading first reported a position in ABBV in Q1 2015 and held it in 25 quarters. The position peaked at $24.6M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Simplex Trading reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 8,076 AbbVie shares in Q1 2026, an estimated $1.79M.
- Simplex Trading first reported a position in AbbVie in Q1 2015 and held it in 25 quarters.
- Simplex Trading's AbbVie position peaked at $24.6M in Q3 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.